Many drug targets are localized to particular subcellular compartments, yet current drug design strategies are focused on bioavailability and tissue targeting and rarely address drug delivery to ...

Utilizing metal–organic frameworks (MOFs) as a biological carrier can lower the amount of the active pharmaceutical ingredient (API) required in cancer treatments to provide a more efficacious therapy ...

Osaka Metropolitan University researchers found that solvent polarity significantly affects how well drugs can be loaded into ...

Even the best products won't meet expectations if they are packed poorly - packaging matters. The same goes for drug delivery.

Solvent polarity plays a critical role in determining how effectively drugs can be loaded into metal-organic framework (MOF) ...

Zeteo Biomedical recently received new patents for its drug delivery technologies ZTech portfolio in both the United States and European Union. 1 The first patent is titled “Cartridge Devices for ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European ...

It offers several unique advantages - it localises drug delivery, maximises dose efficacy and reduces toxicity and side effects. There are currently two types of IDD devices - active and passive, ...